VIJAY SINGH, MD
Rheumatology Physician · SEWELL, NJ
Individual Active NPI 1174786297
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 911 | 200,202 | $10,534,936 | $2,473,025 | $1,942,421 |
| 2023 | 915 | 183,451 | $10,278,902 | $2,451,035 | $1,917,950 |
| 2022 | 1,295 | 196,626 | $11,230,835 | $2,948,379 | $2,286,950 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 121,200 | $4 | $4 |
| J0897 | Injection, denosumab, 1 mg | 20,940 | $25 | $20 |
| J1010 | Injection, methylprednisolone acetate, 1 mg | 19,140 | $0 | $0 |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 13,375 | $42 | $34 |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 10,484 | $11 | $9 |
| 99214 | Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 1,987 | $131 | $94 |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 1,203 | $17 | $13 |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 1,018 | $76 | $60 |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | 437 | $138 | $108 |
| 20610 | Aspiration and/or injection of fluid from large joint | 265 | $80 | $62 |
| 99215 | Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more | 219 | $170 | $129 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 172 | $6 | $4 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Rheumatology Physician | 207RR0500X | ✓ | 25MA08610900 | NJ |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Rheumatology Physician providers in New Jersey
- NPI 1659775344
- NPI 1831449503
- NPI 1275700858
- NPI 1821309154
- NPI 1508244898
- NPI 1396242889
- NPI 1912296278
- NPI 1417994633
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.